DV
Dividend Vision

PLSE — Pulse Biosciences Inc

Pulse Biosciences Inc (PLSE)

Total return is 968.1% over the past 10.2 years, 621.0 points ahead of SPY at 347.1%. Its deepest 1-year drawdown was 36.5%.

PLSE is a single-stock equity holding in Pulse Biosciences Inc, a medical device company operating in the biotechnology sector. The holding does not currently pay distributions and carries no publicly available expense ratio or asset under management data. This security profile appeals primarily to growth-oriented investors seeking exposure to the biotech industry rather than income-focused dividend investors.

PLSE key facts

Asset type
Stock
Asset class
Equity
Inception date
05/18/2016
Last close
$44.54
Market cap
$1,984,934,528
Average volume
401200.0
Beta
1.647
Payout ratio
0.0
Forward P/E
0.0
EPS
$-1.10